FLGT

⬣ Investigation

Fulgent Genetics, Inc.

Securities Investigation

Investigation in Progress — No Complaint Filed Yet

BG&G is actively investigating potential securities fraud claims against Fulgent Genetics, Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.

Why Is Fulgent Genetics, Inc. (FLGT) Under Investigation?

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ: FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Fulgent has violated federal securities laws.

What Potential Securities Violations Is BG&G Investigating?

On February 28, 2025, Fulgent disclosed as part of its annual report filed with the SEC, that it had received a civil investigative demand from the DOJ regarding potentially false claims filed under the Uninsured Program. Following this news, Fulgent stock price dropped.

What’s Next?

If you are aware of any facts relating to this investigation or purchased Fulgent securities, you can assist this investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

How Is Fulgent Genetics, Inc. (NASDAQ: FLGT) Stock Trading Today?

How Does BG&G Help Investors in Securities Fraud Investigations?

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”
— Peretz Bronstein, Founding Partner